{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:24:21Z","timestamp":1794975861991,"version":"4.9.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chengde Medical University Discipline Construction Funds, Chengde Science and Technology Bureau","award":["202204A164"],"award-info":[{"award-number":["202204A164"]}]},{"name":"Chengde Medical University Discipline Construction Funds, Chengde Science and Technology Bureau","award":["202204A164"],"award-info":[{"award-number":["202204A164"]}]},{"name":"Chengde Medical University Discipline Construction Funds, Chengde Science and Technology Bureau","award":["202204A164"],"award-info":[{"award-number":["202204A164"]}]},{"name":"Research Start-up Fund for High-level Talents of Chengde Medical University","award":["202409"],"award-info":[{"award-number":["202409"]}]},{"name":"the Cultivating Programme Plan for Clinical Excellent Talent of Hebei in 2023","award":["ZF2023249"],"award-info":[{"award-number":["ZF2023249"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-97856-w","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T05:49:17Z","timestamp":1745214557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comprehensive analysis of TRIM56\u2019s prognostic value and immune infiltration in Pan-Cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Yunpeng","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingwei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"97856_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"Cancer J. Clin."},{"key":"97856_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/cm9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao, W., Chen, H. D., Yu, Y. W., Li, N. & Chen, W. Q. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin. Med. J. 134, 783\u2013791. https:\/\/doi.org\/10.1097\/cm9.0000000000001474 (2021).","journal-title":"Chin. Med. J."},{"key":"97856_CR3","doi-asserted-by":"publisher","unstructured":"Huang, N. et al. TRIM family contribute to tumorigenesis, cancer development, and drug resistance. Experimental Hematol. Oncol. 11 https:\/\/doi.org\/10.1186\/s40164-022-00322-w (2022).","DOI":"10.1186\/s40164-022-00322-w"},{"key":"97856_CR4","doi-asserted-by":"publisher","first-page":"154811","DOI":"10.1016\/j.prp.2023.154811","volume":"250","author":"T Liu","year":"2023","unstructured":"Liu, T. et al. Role of the tripartite motif (TRIM) family in female genital neoplasms. Pathol. Res. Pract. 250, 154811. https:\/\/doi.org\/10.1016\/j.prp.2023.154811 (2023).","journal-title":"Pathol. Res. Pract."},{"key":"97856_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12929-022-00854-7","volume":"29","author":"K Lu","year":"2022","unstructured":"Lu, K. et al. TRIM proteins in hepatocellular carcinoma. J. Biomed. Sci. 29, 69. https:\/\/doi.org\/10.1186\/s12929-022-00854-7 (2022).","journal-title":"J. Biomed. Sci."},{"key":"97856_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13046-023-02862-3","volume":"42","author":"M Liang","year":"2023","unstructured":"Liang, M. et al. E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells. J. Experimental Clin. cancer Research: CR. 42, 275. https:\/\/doi.org\/10.1186\/s13046-023-02862-3 (2023).","journal-title":"J. Experimental Clin. cancer Research: CR"},{"key":"97856_CR7","doi-asserted-by":"publisher","first-page":"eadh5021","DOI":"10.1126\/science.adh5021","volume":"381","author":"X Gu","year":"2023","unstructured":"Gu, X. et al. The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. Sci. (New York N Y). 381, eadh5021. https:\/\/doi.org\/10.1126\/science.adh5021 (2023).","journal-title":"Sci. (New York N Y)"},{"key":"97856_CR8","doi-asserted-by":"publisher","unstructured":"Wang, L. & Ning, S. TRIMming type I Interferon-Mediated innate immune response in antiviral and antitumor defense. Viruses 13 https:\/\/doi.org\/10.3390\/v13020279 (2021).","DOI":"10.3390\/v13020279"},{"key":"97856_CR9","doi-asserted-by":"publisher","unstructured":"Fu, L., Zhou, X., Jiao, Q. & Chen, X. The functions of TRIM56 in antiviral innate immunity and tumorigenesis. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms24055046 (2023).","DOI":"10.3390\/ijms24055046"},{"key":"97856_CR10","doi-asserted-by":"publisher","unstructured":"Xu, S. et al. TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase. J. Clin. Investig. 134 https:\/\/doi.org\/10.1172\/jci166149 (2024).","DOI":"10.1172\/jci166149"},{"key":"97856_CR11","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"97856_CR12","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"97856_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"Cancer J. Clin."},{"key":"97856_CR14","doi-asserted-by":"publisher","unstructured":"Ge, W. et al. Potential biomarkers: identifying powerful tumor specific T cells in adoptive cellular therapy. Front. Immunol. 13 https:\/\/doi.org\/10.3389\/fimmu.2022.1003626 (2022).","DOI":"10.3389\/fimmu.2022.1003626"},{"key":"97856_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41389-019-0139-x","volume":"8","author":"M Xue","year":"2019","unstructured":"Xue, M. et al. Regulation of Estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56. Oncogenesis 8, 30. https:\/\/doi.org\/10.1038\/s41389-019-0139-x (2019).","journal-title":"Oncogenesis"},{"key":"97856_CR16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13046-022-02534-8","volume":"41","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein. J. Experimental Clin. cancer Research: CR. 41, 336. https:\/\/doi.org\/10.1186\/s13046-022-02534-8 (2022).","journal-title":"J. Experimental Clin. cancer Research: CR"},{"key":"97856_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13046-022-02505-z","volume":"41","author":"J Gao","year":"2022","unstructured":"Gao, J. et al. Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1. J. Experimental Clin. cancer Research: CR. 41, 295. https:\/\/doi.org\/10.1186\/s13046-022-02505-z (2022).","journal-title":"J. Experimental Clin. cancer Research: CR"},{"key":"97856_CR18","doi-asserted-by":"publisher","first-page":"722","DOI":"10.26355\/eurrev_202101_24633","volume":"25","author":"Y Yang","year":"2021","unstructured":"Yang, Y., Mao, F. F., Guo, L. & Guo, W. X. TRIM56 suppresses the malignant development of hepatocellular carcinoma via targeting RBM24 and inactivating the Wnt signaling. Eur. Rev. Med. Pharmacol. Sci. 25, 722\u2013730. https:\/\/doi.org\/10.26355\/eurrev_202101_24633 (2021).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"97856_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3349\/ymj.2018.59.1.43","volume":"59","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. TRIM56 suppresses multiple myeloma progression by activating TLR3\/TRIF signaling. Yonsei Med. J. 59, 43\u201350. https:\/\/doi.org\/10.3349\/ymj.2018.59.1.43 (2018).","journal-title":"Yonsei Med. J."},{"key":"97856_CR20","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1002\/1878-0261.13417","volume":"17","author":"DKH Thng","year":"2023","unstructured":"Thng, D. K. H. et al. Histone-lysine N-methyltransferase EHMT2 (G9a) Inhibition mitigates tumorigenicity in Myc-driven liver cancer. Mol. Oncol. 17, 2275\u20132294. https:\/\/doi.org\/10.1002\/1878-0261.13417 (2023).","journal-title":"Mol. Oncol."},{"key":"97856_CR21","doi-asserted-by":"publisher","unstructured":"De Marco, K., Sanese, P., Simone, C. & Grossi, V. Histone and DNA methylation as epigenetic regulators of DNA damage repair in gastric cancer and emerging therapeutic opportunities. Cancers 15 https:\/\/doi.org\/10.3390\/cancers15204976 (2023).","DOI":"10.3390\/cancers15204976"},{"key":"97856_CR22","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41467-018-04759-8","volume":"9","author":"L Yang","year":"2018","unstructured":"Yang, L. et al. UBXN3B positively regulates STING-mediated antiviral immune responses. Nat. Commun. 9, 2329. https:\/\/doi.org\/10.1038\/s41467-018-04759-8 (2018).","journal-title":"Nat. Commun."},{"key":"97856_CR23","doi-asserted-by":"publisher","unstructured":"Yang, D. et al. The E3 ligase TRIM56 is a host restriction factor of Zika virus and depends on its RNA-binding activity but not MiRNA regulation, for antiviral function. PLoS Negl. Trop. Dis. 13, e0007537. https:\/\/doi.org\/10.1371\/journal.pntd.0007537 (2019).","DOI":"10.1371\/journal.pntd.0007537"},{"key":"97856_CR24","doi-asserted-by":"publisher","unstructured":"Liu, T. et al. Comprehensive Pan-Cancer analysis of KIF18A as a marker for prognosis and immunity. Biomolecules 13 https:\/\/doi.org\/10.3390\/biom13020326 (2023).","DOI":"10.3390\/biom13020326"},{"key":"97856_CR25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","volume":"22","author":"CM Laumont","year":"2022","unstructured":"Laumont, C. M., Banville, A. C., Gilardi, M., Hollern, D. P. & Nelson, B. H. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat. Rev. Cancer. 22, 414\u2013430. https:\/\/doi.org\/10.1038\/s41568-022-00466-1 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"97856_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12943-024-02079-8","volume":"23","author":"X Xia","year":"2024","unstructured":"Xia, X. et al. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy. Mol. Cancer. 23, 175. https:\/\/doi.org\/10.1186\/s12943-024-02079-8 (2024).","journal-title":"Mol. Cancer"},{"key":"97856_CR27","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1016\/j.cell.2024.04.025","volume":"187","author":"MB Maxwell","year":"2024","unstructured":"Maxwell, M. B. et al. ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity. Cell 187, 3390\u20133408e3319. https:\/\/doi.org\/10.1016\/j.cell.2024.04.025 (2024).","journal-title":"Cell"},{"key":"97856_CR28","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.ccell.2024.05.025","volume":"42","author":"G Espinosa-Carrasco","year":"2024","unstructured":"Espinosa-Carrasco, G. et al. Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors. Cancer Cell. 42, 1202\u20131216e1208. https:\/\/doi.org\/10.1016\/j.ccell.2024.05.025 (2024).","journal-title":"Cancer Cell."},{"key":"97856_CR29","doi-asserted-by":"publisher","first-page":"C721","DOI":"10.1152\/ajpcell.00461.2022","volume":"325","author":"DE Jazwinska","year":"2023","unstructured":"Jazwinska, D. E., Kulawiec, D. G. & Zervantonakis, I. K. Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment. Am. J. Physiol. Cell Physiol. 325, C721\u2013c730. https:\/\/doi.org\/10.1152\/ajpcell.00461.2022 (2023).","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97856-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97856-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97856-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:33:18Z","timestamp":1746711198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97856-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97856"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97856-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article Yunpeng Cao,\u00a0Lingwei Kong and Yulu Zhai were omitted as equally contributing authors. The original Article has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have approved the publication of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Supplementary Material 1.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Supplementary Information"}}],"article-number":"13673"}}